Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.97B |
| Enterprise Value | 2.09B |
| P/E Ratio | 3,101.75 |
| PEG Ratio | -34.89 |
| Price/Sales Ratio | 4.8 |
| Price/Book Ratio | 4.39 |
| Enterprise/Revenue | 5.03 |
| Enterprise/EBITDA | 62.52 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | -0.01 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0 |
Income Statement
| Revenue | 537.14M |
| Revenue/Share | 25.22 |
| Gross Profit | 102.25M |
| EBITDA | 45.55M |
| Net Income | 804,000 |
| Diluted EPS | 0.04 |
Balance Sheet
| Total Cash | 38.27M |
| Total Cash/Share | 1.8 |
| Total Debt | 158.34M |
| Total Debt/Equity | 0.26 |
| Current Ratio | 1.22 |
| Book Value Per Share | 28.23 |
Price History
| 52-Week Change | 66.05 |
| 52-Week High | 147 |
| 52-Week Low | 70.84 |
| Moving Average 50 Days | 118.66 |
| Moving Average 200 Days | 116.39 |
Statistics
| Average Volume | 29,718 |
| Shares Outstanding | 20.8M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.02 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
